It did not reduce maternal bile acid concentrations, and the reduction in alanine transaminase was of uncertain clinical significance, given that alanine transaminase is not known to be associated with the risk of stillbirth or preterm labour in intrahepatic cholestasis of pregnancy.1 This evidence concerns the gene GPT and intrahepatic cholestasis.